Who Are We?

XBiotech is a fully integrated biosciences company dedicated to the discovery and development of therapeutic antibodies derived from natural human immunity

XBiotech’s True Human™ antibody candidates are actually derived from donors with natural human immunity. No other marketed antibody product— including “humanized” and so-called “fully human"—are actually derived from natural human immunity.

Clinical Research

Therapeutic areas

Discover our extraordinary innovation and success.

Oncology

Oncology
Oncology

Neurology

Neurology
...more

Rheumatology

Rheumatology
Rheumatology

Anti-infectives

Anti-infectives
Anti-infectives
pipeline

News Updates

news image

Nov 1, 2024

XBiotech Has Non-clinical Data for a Novel Shingles Therapy Ready for IND Submission

XBiotech announces the completion of non-clinical data and is preparing to submit Investigational New Drug (IND) application for their new Unmetix™ cocktail.

Technology

Where Cutting-Edge BioTechnology Meets Natural Human Immunity

True Human™ Antibodies

Harnessing natural human antibody immunity—an intuitive approach to a new generation of medicines.

Manufacturing

State-of-the-art made simple. Engineered, designed and developed at XBiotech.

Biotech news today updates

Pipeline

Unveiling the Future Medicine: Our Pioneering Pipeline of True Human Antibodies

Our pipeline addresses a wide range of unmet medical needs.